期刊文献+

肺泡上皮腺瘤样增生与细支气管肺泡癌的关系探讨 被引量:2

THE RELATIONSHEP BETWEEN ADENOMATOUS HYPERPLASIA OF ALVEOLAR EPITHELIUM AND BRONCHIOALVEOLAR CARCINOMA
原文传递
导出
摘要 对7例细支气管肺泡癌合并肺纤维化及4例单纯性肺纤维化手术病例,进行病理形态及免疫组织化学检查,讨论了肺泡上皮腺瘤样增生(AH)的形态、组织发生及与细支气管肺泡癌的关系。根据光镜下形态学改变特点,将AH分为Ⅰ、Ⅱ两型,本组Ⅰ型AH6例、Ⅱ型AH5例。抗SA、抗SSEA-1及抗CEA单抗检查结果表明,AH是慢性炎症性肺疾患时肺泡上皮出现的非特异性增生性病变,Ⅰ、Ⅱ两型AH均来源于B型肺泡上皮细胞;后者在前者基础上发展形成,较前者更具幼稚化倾向及增生能力,为一种癌前病变。细支气管肺泡癌中一部分起源于B型肺泡上皮细胞,可以认为其中有的是经Ⅱ型AH癌变而形成。 Abstract Surgical specimens of 7 cases of bronchioalreolar carcinoma complicated with pulmonaryfibrosis and 4 cases of simple pulmonary fibrosis were examined histopathologically and immunohistochemically.The morphology and histogenesis of adenomatous hyperplasia(AH)ofalveolar epithelium and its rdlation to btonchioalveolar carcinoma were investigated.The AH wasclassified as types Ⅰand Ⅱaccording to their microscopic morphologic characteristics.In this group,6 cases of type Ⅰ-AH and 5 cases type Ⅱ-AH were observedThe results of anti-SA, an-ti-SSEA-1 and anti-CEA monoclonal antibody examinations indicate that AH is a nonspecifichyperplastic lesion of alveolar epithelium occurre d during chronic pulmonary inflammatory diseases.Both type Ⅰ and Ⅱ AH originated from type B alveolar epithelial cellsThe latter developed on the basis of the formerbut with a more immatute tendency and byperplastic pltemtialbeing apre-malignant alterationIt could be considered that certain ca ses of bronchioalveolar carcinomaa are originated form type B alveolar epithelial cells,some of which underwent malignant changefrom type Ⅱ alveolar hyperplasia.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 1994年第2期141-143,T004,共4页 Chinese Journal of Oncology
  • 相关文献

参考文献1

  • 1张林,J Clin Electron Microscopy,1989年,22卷,884页 被引量:1

同被引文献10

  • 1Barsky SH, Cameron R, Osann KE, et al. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer, 1994, 73 : 1163-1170. 被引量:1
  • 2Kwiatkowski DJ, Harpole DH, Godleski J, et al. Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications. J Clin Oncol, 1998,16:2648-2677. 被引量:1
  • 3Breathnach OS, lshibe N, Williams J, et al. Clinical features of patients with stage Ⅲ B and Ⅳ bronchioloalveolar carcinoma of the lung. Cancer, 1999, 86 : 1165-1173. 被引量:1
  • 4Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med, 2002, 346:92-98. 被引量:1
  • 5Feldman ER, Eagan RT, Schaid DJ. Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: comparison of clinical manifestations, chemotherapeutic responses and prognosis. Mayo Clin Proc, 1992, 67:27-32. 被引量:1
  • 6West HL, Crowley J J, Vance RB, et al. Advanced bronehioloalveolar carcinoma: a phase Ⅱ trial of paclitaxel by 96- hour infusion(SWOG 9714) : a southwest oncology group study. Ann Oncol, 2005, 16 : 1076-1080. 被引量:1
  • 7Williams DE, Pairolero PC, Davis CS, et al. Survival of patients surgically treated for stage Ⅰ lung cancer. J Thorac Cardiovasc Surg, 1981, 82: 70-76. 被引量:1
  • 8Kris MG, Natale RB, Herbst RS, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer:a randomized trial. JAMA, 2003, 290: 2149-2158. 被引量:1
  • 9West HL, Franklin WA, McCoy J, et al. Gefitinib therapy in advanced bronchioloalvelar carcinoma: southwest oncology group study S0126. J Clin Oncol, 2006, 24: 1807-1813. 被引量:1
  • 10余辉,吴一龙,戎铁华,王思愚,区伟,杨学宁.细支气管肺泡癌52例临床分析[J].中华肿瘤杂志,2001,23(4):344-346. 被引量:22

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部